Catapres-tts-1 Patch
Product Images NDC 82089-101

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Catapres-tts-1 (NDC 82089-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Technomed Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.1 mg Adhesive Cover Pouch)

This is a warning about an adhesive cover that does not contain active medication. The cover should be applied over the patch if necessary. There are patient instructions available for use of the adhesive cover. The product code is L15000B 10003925/02.*

FDA Label Image

Principal Display Panel (0.2 mg Adhesive Cover Pouch)

This appears to be a product label or packaging insert for an adhesive cover containing no active medication, to be used as per patient instructions. The label contains several warnings, instructions and a product code.*

FDA Label Image

Principal Display Panel (0.3 mg Adhesive Cover Pouch)

This is a warning label for an adhesive cover that should be used for external application only. It does not contain any active medication. It is advised to refer to the patient instructions before use. The product code is L15002A 10003923/02.*

FDA Label Image

Catapres-tts-structure (Catapres Tts Structure)

FDA Label Image

Cross-section-table (Cross Section Table)

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Figure-2 (Figure 2)

This appears to be a medication packaging label that includes a patch. The label suggests that the package contains a patch with medication and also includes a cover that can be used if the patch becomes loose.*

FDA Label Image

Figure-3 (Figure 3)

FDA Label Image

Figure-4 (Figure 4)

FDA Label Image

Figure-5 (Figure 5)

FDA Label Image

Figure-6 (Figure 6)

FDA Label Image

Principal Display Panel (0.1 mg Patch Pouch Label)

Catapres-TTS is a transdermal system that delivers clonidine in vivo to provide 0.1mg per day for seven days consecutively. The transdermal system should be removed before undergoing an MRI procedure. Each patch contains one medication, and you should remove the clear backing before using it. The patch should be stored at controlled room temperature, between 15°C to 30°C (59°F to 86°F). The manufacturer of Catapres-TTS is Alza Corporation, Vacaville, CA.*

FDA Label Image

Principal Display Panel (0.2 mg Patch Pouch Label)

Catapres-TTS"-2 is a transdermal system that delivers 0.2mg clonidine per day for one week. The patch should be removed before an MRI procedure to avoid burns. The medication is contained in a single patch that should be stored within the temperature range of 15°C-30°C. The product is manufactured by Alza Corporation, and Catapres-TTS is a registered trademark of Boehringer Ingelheim International GmbH.*

FDA Label Image

Principal Display Panel (0.3 mg Patch Pouch Label)

Catapres-TTS®-3 is a transdermal system that delivers clonidine in vivo at a rate of 0.3 mg per day for one week. The patch needs to be removed before undergoing an MRI procedure. The pouch contains one patch with medication. The clear backing needs to be removed before using it. It needs to be stored at 25°C (77°F) with permitted excursions to 15°-30°C (59°-86°F). The product is manufactured by Alza Corporation in Vacaville, CA 95688, USA. Tear here to remove the patch.*

FDA Label Image

Principal Display Panel (0.1 mg Patch Pouch Carton)

This text contains a mix of random errors and incomplete sentences. As a result, it does not convey any useful information and cannot be evaluated.*

FDA Label Image

Principal Display Panel (0.2 mg Patch Pouch Carton)

FDA Label Image

Principal Display Panel (0.3 mg Patch Pouch Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.